RUSSIAN NATIONAL SCIENTIFIC ANATOMICAL JOURNAL

Preview

Morphological newsletter

Advanced search

THE COMPARATIVE MORPHOLOGICAL ANALYSIS OF THE NEPHROTOXICITY OF DOXORUBICIN AND NANOSTRUCTURED DOXORUBICIN IN CONDITIONS OF TRANSPLANTABLE CARCINOGENESIS

https://doi.org/10.20340/mv-mn.18(26).02.45-48

Abstract

The study was carried out on 120 mongrel white laboratory rats, to whom were transplanted the ascitiс Zaidel's hepatoma and which were divided into three equal groups. Of these, the first group of animals was a control group without treatment. In the second group, to animals doxorubicin was injected, in the third group, nanostructured doxorubicin was injected to the animals for 21 days. The aim of the study was to assess the degree of morphological changes in the tubules and glomeruli of the kidneys under the influence of nanostructured doxorubicin and doxorubicin in the condition of transplantable carcinogenesis. Given the nephrotoxicity of the chemotherapy drugs studied, the dynamics of structural changes in the tubules and glomeruli of the kidneys was studied. Conducted a comparative morphological evaluation of the changes occurring in the kidneys. The results of a morphological study of the structural components of the kidneys prove that doxorubicin and nanostructured doxorubicin have different effects on both the tubular apparatus and the glomeruli of the kidneys in the condition of transient carcinogenesis. The use of doxorubicin is accompanied by a relatively pronounced nephrotoxic effect, which is indicated by dystrophic and necrobiotic changes in the epithelium of convoluted tubules and the glomerular apparatus of the kidneys. The use of nanostructured doxorubicin is limited to moderately expressed dystrophic changes in the epithelium of the tubular apparatus of the kidneys, the glomerular apparatus remains intact at the same time. Thus, the use of the preparation of nanostructured doxorubicin for the treatment of the ascitic hepatoma of Zaidel in experimental animals has a less pronounced toxic and damaging effect on the renal parenchyma.

About the Authors

I. N. Chairkin
Sechenov First Moscow State Medical University
Russian Federation


N. V. Chairkina
Ogarev National Research Mordovian State University
Russian Federation


O. N. Deryabina
Ogarev National Research Mordovian State University
Russian Federation


V. Y. Medvezhonkov
Ogarev National Research Mordovian State University
Russian Federation


O. V. Kalmin
Penza State University
Russian Federation


References

1. Reshetarova DA. Analiz onkologicheskoj zabolevaemosti naseleniya PFO [Elektronnyj resurs] Sovremennye problemy territorial'nogo razvitiya: elektron. zhurn. 2018;2 ID 39 ISSN:2542-2103.

2. Terasaki T, Iga T, Sugiyama Y, Sawada Y, Hanano M. Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D. J Pharmacobiodyn. 1984;7(5):269-277.

3. Matyash MG, Kravchuk TL, Vysockaya VV, Chernov VI, Gol'dberg VE. Inducirovannaya antraciklinami kardiotoksichnost': mekhanizm razvitiya i klinicheskie proyavleniya. Sibirskij onkologicheskij zhurnal. 2008;6(30):66-75.

4. Ipatova OM, Zykova MG, Torhovskaya TI, Medvedeva NV, Prozorovskij VN. Vozmozhnosti ispol'zovaniya fosfolipidnoj nanosistemy s glicirrizinovoj kislotoj (Fosfogliv) dlya optimizacii lekarstvennyh preparatov, na primere doksorubicina i budesonida. Biomedicinskaya himiya. 2009;55(2):185-194.

5. Pyataev NA, Shchukin SA, Korovina EYu, Zyrnyaeva NN. Osobennosti tkanevogo raspredeleniya i protivoopuholevoj aktivnosti doksorubicina pri vvedenii v forme kon"yugata s DNK u krys s transplantirovannoj karcinomoj RS-1. Rossijskij bioterapevticheskij zhurnal. 2011;10(2):55-61.

6. Ying XY, Du YZ, Chen WW, Yuan H, Hu FQ. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release. Pharmazie. 2008;63(12):878-882.

7. Allen TM, Cullis PR. Liposomal drag delivery system: From concept to clinical applications. Adv Drag Deliv Rev. 2013;65:36-48.

8. Alekseev KV, Alyautdin RN, Blynskaya EV, Kvinh BT. Nanorazmernye sistemy dostavki lekarstvennyh veshchestv. Vestnik novyh medicinskih tekhnologij. 2009;16(2):17-20.

9. Baryshnikov AYu. Nanostrukturirovannye liposomal'nye sistemy kak sredstvo dostavki protivoopuholevyh preparatov. Vestnik RAMN. 2012;3:23-30.

10. Tsyganova NA, Khayrullin RM, Terentyuk GS, et al. Pronitsaemost' pegilirovannykh zolotykh nanochastits cherez gematoplatsentarnyy bar'er krys// Byulleten' eksperimental'noy biologii i meditsiny. 2014;15 (3): 366-369.

11. Sharafutdinova LA, Khismatullina ZR, Daminov MR, Valiullin VV. The study of embryotoxic effect of titanium dioxide nanoparticles on rats. Morfologicheskie Vedomosti -Morphological Newsletter. 2017;25(3):37-42.


Review

For citations:


Chairkin I.N., Chairkina N.V., Deryabina O.N., Medvezhonkov V.Y., Kalmin O.V. THE COMPARATIVE MORPHOLOGICAL ANALYSIS OF THE NEPHROTOXICITY OF DOXORUBICIN AND NANOSTRUCTURED DOXORUBICIN IN CONDITIONS OF TRANSPLANTABLE CARCINOGENESIS. Morphological newsletter. 2018;26(2):45-48. (In Russ.) https://doi.org/10.20340/mv-mn.18(26).02.45-48

Views: 374


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1812-3171 (Print)
ISSN 2686-8741 (Online)